| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.4 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |